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Introduction
Uveitis, the most common formof  inflammatory eye disease, is
an important public health concern.
It accounts for a significant percent-
age (estimated at 10–15%) of  preva-
lent cases of  legal blindness in the
United States.1 The most frequent
subtype is anterior uveitis, represent-
ing up to 92% of  total cases in com-
munity-based ophthalmic practices.2
HLA (human leukocyte antigen)-
B27 positivity, a human major his-
tocompatibility complex (MHC), is
the most common identifiable cause
of  anterior uveitis and accounts for
about 50% of  the cases in different
populations.3,4 HLA-B27-associated
uveitis is characterized by recurrent
alternating acute unilateral attacks
of  intraocular inflammation of  the
anterior segment of  the eye, and
typically affects young male adults.5
In uveitis related to HLA-B27, the
presence of  a hypopyon – a layer
of  white blood cells in the anterior
chamber – and posterior segment
involvement of  the eye are uncom-
mon.
A hypopyon suggests severe
anterior segment intraocular inflam-
mation and is a rare occurrence in
patients with uveitis, occurring in
less than 1% of  all uveitis patients.6
Posterior segment involvement,
namely intermediate and/or pos-
terior uveitis, is also infrequent and
has been reported in up to 25%
of  HLA-B27-associated uveitis
cases.7-10 Furthermore, anterior and
intermediate uveitis cases have a
lower risk of  hypopyon compared to
patients with only anterior uveitis.6
This report highlights an atypical
case of  HLA-B27-associated uveitis
that presented with both a hypopyon
and severe intermediate uveitis in an
elderly man.
Case report
A 60-year-old Caucasian male was
seen in the eye clinic of  a hospital
reporting a red, painful right eye
with decreased vision. The patient
was in fact seen three days earlier for
pain and inflammation from a right
shoulder injury for which he was
put on a narcotic analgesic (oxy-
codone 5 mg and acetaminophen
325 mg marketed as Percocet, one
tablet every four hours as needed).
The onset of  his ocular symptoms
coincided with the introduction of
Percocet so he discontinued the
drug after one day, however, his
vision continued to worsen. Ocular
history was unremarkable with no
reports of  trauma, surgery, inflam-
mation or infection. Medication was
limited to the recent use of  Percocet
for the shoulder and the occasional
nonsteroidal anti-inflammatory drug
(naproxen) for nonspecific pain in
the body with no reported allergies
to any medication. Review of  all
systems revealed episodes described
as podagra (i.e. inflammation on the
big toe related to episodes of  gout)11
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within the past year (although he was
never officially diagnosed with gout)
and a history of  papular rashes on
his forehead and both his shins with
mild erythema and some excoria-
tion (abraded areas where the skin
is torn or worn off). Upon further
questioning, the patient reported
no history of  ulcers, sores, irritable
bowel disease, bloody stool, urina-
tion difficulties or shortness of
breath. The patient’s family history
was unremarkable. The patient also
denied excessive nicotine or alcohol
use, and had not engaged in any
sexual activity recently. The patient
was oriented to time, place and per-
son, and was lucid at the time of  the
examination.
Upon ocular examination, visual
acuity (VA) was hand motion OD
(without improvement with pinhole)
and 20/30 OS. Slit lamp examina-
tion of  the right eye revealed 2+
injection of  the bulbar conjunctiva.
Fine keratic precipitates (KPs) were
widely distributed throughout the
cornea, although no corneal thin-
ning was noted. Anterior chamber
(AC) examination of  the right eye
revealed 4+ cells and flare (without
convection current), fibrin produc-
tion with a 1.5 mm hypopyon in the
lower quadrant as seen in Figure 1. 
Dilated funduscopic examination
(DFE) revealed severe vitreous haze
(grade 4+ vitreous cells), obstructing
all view to the retina. B-scan ultra-
sound revealed extensive vitreous
debris. The left eye revealed only an
early nuclear sclerotic cataract with
no evidence of  active or past inflam-
mation. A summary of  the ocular
findings is shown in Table 1.
Given the B-scan, the patient was
diagnosed with acute unilateral
nongranulomatous anterior and
intermediate hypopyon uveitis, with
a tentative HLA-B27 association.
The patient received 125 mg of
intravenous anti-inflammatory
glucocorticoid (methylprednisolone
sodium succinate) coupled with a
topical anti-inflammatory corticoste-
roid (1% prednisolone acetate qh, 
with a loading dose before bedtime
and upon awakening), a cycloplegic/
mydriatic agent (atropine 1% tid),
and an oral anti-inflammatory
corticosteroid (prednisone 80 mg
daily). The patient was then sent to
the laboratory to have his blood
drawn for further analysis.
A subsequent review of  his
laboratory examination revealed an
elevation of  ESR, CRP and white
blood cells. Laboratory results were
positive for the following markers:
HLA-B27, HSV IgG and HSV IgM.
(SeeTable 2) The remainder of  the
work-up, including ACE, Toxoplas-
ma, FTA-ABS, RPR and VZV titre,
was negative. The etiology of  the
uveitis was thus confirmed as  HLA-
B27 positivity. The patient did not
have a primary care provider, so a
consultation with a rheumatologist
was recommended.
The patient responded well to
therapy. Ten days after treatment
was initiated, VA of  the right eye
improved to 20/60, IOP was
16 mmHg, anterior segment re-
vealed few fine KPs inferiorly, 1+
cells and flare in the AC and a
<0.5 mm hypopyon. A DFE dem-
onstrated 1+ anterior vitreous cells,
snowbanks and snowballs resting
Figure 1 – A hypopyon (height of
1.5mm) seen at the lower quadrant of
the anterior chamber
Table 1: Clinical findings at initial presentation
rIgHT EYE (OD) LEFT EYE (OS)
Visual acuity Hand motion 20/30
Pupil reactions Normal Normal
Extraocular movements Normal Normal
Tonometry (Tonopen) 21 mmHg 22 mmHg
Bulbar conjunctiva 2+ injection
Unremarkable
Cornea Fine keratic precipitates widely distributed
Anterior chamber 4+ cells and flare, fibrin production with a 1.5 mm 
high hypopyon, grade IV Van Herick angle
Crystalline lens 1+ nuclear sclerotic cataract without posterior 
synechiae
Posterior segment Severe vitreous haze (grade 4+ vitreous cell) with 
extensive vitreous debris
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inferiorly. The macula, optic disc and
the rest of  the retina were unremark-
able. Due to the marked subjective
and objective improvement, tapering
of  oral prednisone was initiated (60
mg for 5 days, 40 mg for 5 days, 30
mg for 5 days, 20 mg for 5 days, 10
mg for 5 days, 5 mg for 5 days, then
discontinued).
At week 3, clinical evolution was
favourable with VA at 20/30-2. The
KPs and hypopyon disappeared
(Figure 2), however grade 0.5+ cells
and flare remained in the AC, grade
0.5+ cells in the anterior vitreous,
and persistent snowbanks and snow-
balls. The left eye remained stable
and quiet throughout the episode.
At his last follow up at week nine,
the patient had already discontinued
both systemic and topical medication
a week prior. His VA was maintained
 at 20/30-1, IOP was 16 mmHg,
anterior segment was unremarkable,
and a posterior segment examination
revealed grade 0.5+ vitreous cells,
inferior snowballs from five to eight
o’clock. The patient was to return for
regular monitoring in one month.
Discussion 
The differential diagnosis for this
patient included infectious and non-
infectious etiologies for the uveitis,
which includes, HLA-B27 positivity,
Herpes simplex virus (HSV), Be-
hçet’s disease, sarcoidosis, toxoplas-
mosis, Varicella-zoster virus (VZV),
syphilis and tuberculosis. Multiple
sclerosis, Lyme disease and Barton-
ella, although less probable culprits,
could also have been on the list of
differentials. A brief  description of
each can be found in Table 3. 
The patient was initially diagnosed
with an acute nongranulomatous
uveitis with a tentative HLA-B27
association, however, the hypopyon
and intermediate uveitis were atypi-
cal. Ramsay and Lightman (2001)
classified the causes of  hypopyon
into non-infectious causes, infec-
tious agents, neoplasms, and corneal
disorders.26 Table 4 shows the most
common differential diagnosis for
hypopyon, anterior uveitis and inter-
mediate uveitis.
In both intraocular infection and
inflammation, hypopyon consists
largely of  tissue debris, fibrin,
inflammatory by-products and leu-
kocytes, and signifies severe anterior
segment intraocular inflammation.6
A study by Zaidi et al,6 indicates that
hypopyon is an uncommon finding
in patients with uveitis, occurring in
around 8.57 patients per 1000
person-years (0.86%), even in ter-
tiary uveitis practices. This retrospec-
tive study indicated that hypopyon
was more common among patients
with uveitis limited to the anterior
chamber than in patients who also
had intermediate uveitis as a part
of  their diagnosis, but was nearly
Figure 2: Anterior segment photo 
illustrating the resolved hypopyon and a 
clear anterior chamber
pUrpOSE NOrmAL vALUES rESULT
Erythrocyte 
Sedimentation Rate (ESR)
Inflammation ≤ 30 mm/hr Elevated (110 mm/hr)
C-Reactive Protein (CRP) Inflammation <6 mg/L Elevated (19.35 mg/L)
White blood cells Inflammation 4 × 109 to
1.1 × 1010/L
Mild leukocytosis  
(13.1 x 109/L)
Human Leukocyte 
Antigen B27 (HLA-B27)
Specific protein 
strongly associated with 
spondyloarthropathies
Negative Positive
Herpes Simplex Virus 
(HSV) IgG
Herpes simplex  
virus-specific antibody
Negative Positive
Herpes Simplex Virus 
(HSV) IgM 
Herpes simplex  
virus-specific antibody
Negative Positive
Angiotensin-Converting 
Enzyme (ACE)
Sarcoidosis Negative Negative
Toxoplasma Toxoplasmosis Negative Negative
Treponema Pallidum 
Antibody (FTA-ABS)
Syphilis Negative Negative
Rapid Plasma Regain 
(RPR)
Syphilis Negative Negative
Varicella-Zoster Virus 
(VZV) titer
Varicella zoster virus 
antibodies
Negative Negative
Table 2: Clinical laboratory results
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as frequent among patients with
posterior or panuveitis. The most
common risk factors for hypopyon
are Behçet’s disease and HLA-B27
positivity, conferring respectively an
approximate five-fold and two-fold
increased risk of  hypopyon.  In fact,
HLA-B27 hypopyon uveitis occurs
in 5.7% of  all uveitis cases and is
more common among Caucasians.27
Even though hypopyon is an indica-
tor of  remarkably severe inflamma-
tion, eyes that develop hypopyon do
not appear to have adverse visual
outcomes more often than eyes
without it. A previous study on
Behçet’s disease showed that patients
who developed hypopyon were
more likely to gain three lines of
vision at any point during follow-up,
probably because the haze associated
with a hypopyon was a reversible
cause of  vision loss.28
Intermediate uveitis is diagnosed
when intraocular inflammation pri-
marily involves the vitreous, periph-
eral retina and pars plana ciliaris.29
It is the type of  uveitis with the
longest clinical duration.30 The syn-
drome is more frequent in the third
and fourth decade.31 Intermediate
uveitis has been reported to make
up 1.4 – 22% of  all uveitis cases.32
Although the majority of  cases are
of  unknown etiology, a significant
association between intermediate
uveitis and multiple sclerosis, sar-
coidosis and Lyme disease has been
reported.33, 34 Intermediate uveitis is
bilateral 80% of  the time. Main
clinical features are vitreous cells,
with or without snowballs and snow
banking. The intermediate uveitis
found in this case was atypical in that
it was monocular and not associated
with the aforementioned diseases.
In the case reported here, the
patient’s laboratory results were posi-
tive for HLA-B27, HSV IgG and
HSV IgM, which pointed towards
an etiology of  either an HLA-B27-
associated uveitis or Herpes simplex
uveitis.
Acute HSV uveitis is typically sec-
ondary to herpetic keratitis, although
15% of  patients may not experience
corneal involvement.35, 39 Clinical
signs of  HSV uveitis include corneal
scarring, focal or patchy iris atrophy,
iris transillumination defects, KP,
gENErAL DESCrIpTION OCULAr mANIFESTATIONS
HLA-B27 positivity5 Genetic marker associated with spondyloarthropathies 
Most common identifiable cause of anterior uveitis (50%)
Anterior uveitis
Herpes simplex  
uveitis12, 13, 35-38
Uveitis caused by Herpes simplex virus
Secondary to herpetic keratitis
Absence of corneal disease in 15%
Corneal scarring
Unilateral recurrent anterior uveitis
Iris atrophy, elevated IOP, KPs and synechiae
Hypopyon possible
Posterior segment inflammation in 15%
Behçet’s disease14 Systemic vasculitis disorder of unknown etiology
Relapsing episodes of oral ulcers, genital ulcers and skin lesions
Sudden attacks of anterior uveitis with hypopyon
Sarcoidosis15, 16, 17 Chronic non-caseating granulomatous systemic disease of 
unknown etiology
A third of patients have ocular involvement
Chronic bilateral anterior uveitis
Iris nodules, posterior synechiae, KPs and peripheral 
anterior synechiae
Posterior segment involvement possible
Toxoplasmosis2, 18, 19 Infection caused by the parasite Toxoplasma gondii
Most common infectious cause of intraocular inflammation in 
immunocompetent patients
Can cause anterior uveitis and retinal vasculitis
Herpes zoster 
ophthalmicus   
(ocular shingles) 20
Reactivation of the Varicella-zoster virus
50% develop ocular complications, with uveitis occurring in 43%
High incidence of secondary glaucoma
Uveitis is uniphasic and short-lived
Syphilis21-24 Sexually-transmitted infectious disease by Treponema pallidum
Many people do not have symptoms
Can initially present as anterior uveitis
Can mimic many ocular conditions
Uveitis can be unilateral or bilateral, acute or chronic
Can cause hypopyon
Tuberculous uveitis25 Rare
Caused by Mycobacterium tuberculosis
2% of active tuberculosis
Chronic granulomatous anterior uveitis
Disseminated choroiditis with vitritis
Cystoid macular oedema
Table 3: Possible etiologies for uveitis
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posterior synechiae, and elevated
IOP.39-41 A unilateral anterior uveitis
coupled with an elevated IOP point
to HSV uveitis. The presence of
patchy iris atrophy and transillumina-
tion defects corroborates the diag-
nosis. Since the clinical presentation
of  this case did not involve the iris
or an elevated IOP, HSV uveitis was
rejected as a potential diagnosis and
HLA-B27 positivity was favoured as
the main etiology.
Despite the atypical presentation,
the prognosis was positive for this
patient, like in most HLA-B27-
associated uveitides. With only topi-
cal and systemic steroids, the clinical
progression was favourable and
the patient regained VA to 20/30-1
within 9 weeks. The patient suf-
fered from inflammation of  his right
shoulder just before the onset of
his uveitis attack. It is unclear at this
time whether the shoulder inflam-
mation and the uveitis are
two separate inflammatory events,
or whether they are part of  a
single systemic problem. HLA-B27-
associated anterior uveitis patients
with concomitant posterior segment
manifestations have a significantly
higher incidence of  associated 
systemic diseases, namely ankylosing
spondylitis, inflammatory bowel dis-
eases or reactive arthritis (formerly
referred to as Reiter’s syndrome).42
Thus, a referral to rheumatology
was recommended to rule these out.
The patient has been educated that
recurrences are highly possible, and
that this process may be part of  a
systemic inflammatory condition,
which may require steroids and/or
chronic immunosuppressive therapy.
However, the patient was not seen in
a follow-up after the referral.
hLA-b27-associated uveitis
As the most common specific
uveitis diagnosis, HLA-B27-
associated uveitis accounts for
approximately 13–17% of  all 
uveitis cases.2, 43 About 50% of
patients suffering from acute
anterior uveitis are HLA-B27 posi-
tive.5 HLA-B27-associated uveitis 
is three times more common in 
males.44 The average age of  onset
of  the disease is 35, although cases 
have been reported in children 
(10% of  cases begin prior to 20 
years old) and late adulthood (5% 
after 55 years of  age).10
The classic presentation of
HLA-B27-associated ocular disease
is acute anterior uveitis (AAU).10 The
onset is typically abrupt and symp-
toms include photophobia, ocular
pain, epiphoria, ocular redness, and
mild-to-severe visual blurring. Cases
are generally unilateral but a recur-
rent attack may affect the contralat-
eral eye. Although the inflammation
is usually nongranulomatous, it may
be severe enough to cause a hypo-
pyon or a plasmoid aqueous.
HLA-B27-associated AAU is in fact
the most common cause of  hypo-
pyon uveitis in North America.27
Uncommon cases (less than 25.1%)
cases may involve the posterior
segment.7 Such posterior segment
involvement is recognized as vitritis,
cystoid macular oedema, papillitis
and retinal vasculitis, and is thought
to be secondary to anterior segment
inflammation.10, 45 Thus, HLA-B27-
associated uveitis may be unusually
severe and may cause a panuveitis,
which is an under-recognized
phenomenon.46 During an acute
attack, IOP is generally lowered due
to the shutdown of  the ciliary body.
Nevertheless, increased IOP
and secondary glaucoma is a
Table 4: Most common differential diagnosis of hypopyon, anterior uveitis and intermediate uveitis
HYpOpYON ANTErIOr UvEITIS INTErmEDIATE UvEITIS
l		Non-infectious
HLA-B27
Behçet’s disease
Spondyloarthropathy
Iatrogenic/Neoplasm/Trauma
l		Infectious
Endogenous endophthalmitis
Toxoplasmosis
Syphilis
Hansen’s disease
Brucellosis
HSV
Keratitis
l		Other
l		Idiopathic
l		hLA-b27
l		Reactive arthritis (Reiter’s syndrome)
l		Ankylosing spondylitis
l		Sarcoidosis
l		Syphilis
l		hSV
l		Trauma
l		Posner-Schlossman Syndrome
l		Neoplasm
  Lymphoma, leukemia, retinoblastoma
l		Other
l		Idiopathic
l		Multiple sclerosis
l		Sarcoidosis
l		Lyme disease
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well-recognized complication due to
iris bombé or synechial angle
closure. Uveitis attacks are normally
short-lived and resolve within three
months. Recurrent episodes are
common, but the frequency varies
between multiple attacks per year to
single attacks separated by one or
more decades.46
There is a stepladder approach
to the management of  uveitis.47
The immediate goal is to control
the inflammation and ciliary spasm,
with a long-term goal of  addressing
the underlying cause of  the uveitis.
First-time occurrences and uncom-
plicated recurrences can be treated
with topical corticosteroid, such as
prednisolone acetate 1%, which has
a moderate potency and is appropri-
ate for many cases. Although the risk
of  systemic side effects is low, 1% of
patients experience increased IOP,
in which case a milder formulation
such as rimexolone and lotoprednol
can be utilized.48 The concomitant
use of  a cycloplegic/mydriatic
drop, such as atropine sulphate 1%,
reduces pain from ciliary spasm
and may break or prevent posterior
synechiae.
More severe cases may require
a combination of  oral, topical,
periocular or intravitreal treatments.
Systemic corticosteroid administra-
tion is required in 24% of  patients.
A typical oral starting dose is 1 mg/kg
of  prednisone daily. Side effects
resulting from a short course of
systemic steroids are infrequent but
include sleep disturbances, weight
gain, increased appetite, mood im-
balance and more.49 In extreme cases
of  uveitis involving the posterior
segment, periocular or intravitreal
corticosteroids may be considered.50
Periocular injections (transseptally,
in the sub-tenon’s space or subcon-
junctivally) are designed as depot
injections (e.g. triamcinolone acetate)
and therefore, are effective for an
extended period of  time.51 Intravit-
real injections are effective for three
to six months, minimize systemic
side effects, and have the benefit
of  treating macular oedema caused
by posterior uveitis.52 On the other
hand, ocular complications (e.g. cata-
racts and increased IOP) are more
common with intravitreal injections
than with systemic steroids.
Extreme sight-threatening cases
may require pulse intravenous (IV)
steroids to bring the inflammation
under control more quickly and to
prevent irreparable damage. The
recommended regimen for such
cases is methylprednisolone 1 g IV
per day for 3 days, with subsequent
transition to oral therapy, starting at
1 mg/kg per day.47, 53, 54 For recalci-
trant cases, steroid-free strategies can
be considered, such as oral NSAID
therapy or immunosuppressive
therapy.55, 56, 47
Patients on topical or systemic
steroids for an extended period of
time (i.e. over two weeks) should
be tapered off  over the course of
several weeks to avoid rebound
inflammation after topical use, or
inducing adrenal crisis from abrupt
stoppage of  oral corticosteroid use.
Patients requiring immunosuppres-
sive therapy should remain on their
regimen without dose reductions to
prevent any recurrences, which may
be difficult to control.
HLA-B27 testing in patients with
uveitis is useful because it may help
to identify a previously undiagnosed
systemic disease. Among patients
with HLA-B27-associated uveitis,
around 70% will have an associ-
ated (rheumatoid factor) seronega-
tive spondyloarthropathy of  which
approximately 50% will not have
been diagnosed or will have been
misdiagnosed. Seronegative spon-
dyloarthropathy includes ankylosing
spondylitis, reactive arthritis (Reiter’s
syndrome), psoriatic arthropathy,
and arthritis associated with inflam-
matory bowel disease. Patients with
posterior segment manifestations
have a significantly higher incidence
of  such systemic diseases.42, 57 In ad-
dition, around 30 – 90% of  patients
with HLA-B27-associated uveitis
suffer from associated joint disease.58
As a result, HLA-B27 testing can be
beneficial in improving management
of  the patient’s overall systemic
health.
Summary
In this case report, a final diagnosis
of  HLA-B27-associated uveitis was
made following an extensive clinical
and laboratory evaluation despite the
atypical presentation. The hypopyon
and its associated anterior and in-
termediate uveitis were successfully
treated with topical and systemic
steroids. This case is an important
reminder that, although uncommon,
hypopyon and posterior segment
involvement may be present in an
HLA-B27-associated uveitis, and can
even affect the elderly. Furthermore,
it is important to include a com-
prehensive assessment of  both the
anterior and posterior segments of
any presenting painful, red eye for a
full clinical appreciation.
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